Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001249731 | SCV001423762 | likely pathogenic | CIC-related neurodevelopmental disorders | 2019-12-06 | criteria provided, single submitter | clinical testing | The CIC c.680A>G (p.Asn227Ser) variant, also referred to as c.3407A>G (p.Asn1136Ser), is a missense variant that has been reported in one male in a de novo heterozygous state. This individual had mild intellectual disability and did not have dysmorphic features, had normal genitalia, normal growth, and normal hearing and vision. In addition, no malformations or seizures were noted. Additional clinical feature were not described (Athanasakis et al. 2014). This variant is not found in the Genome Aggregation Database in a region of good sequence coverage, so the variant is presumed to be rare. Even though clinical evidence for the variant is limited, based on the de novo nature of the variant and absence from population frequency databases, the p.Asn227Ser variant is classified as likely pathogenic for CIC-related neurodevelopmental disorders. |
Rady Children's Institute for Genomic Medicine, |
RCV001265571 | SCV001443733 | likely pathogenic | Intellectual disability, autosomal dominant 45 | 2019-11-19 | criteria provided, single submitter | clinical testing | This variant has been previously reported as a de novo change in a patient with intellectual disability (ID) (PMID: 24307393). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. In silico analyses support a deleterious effect of the c.680A>G, p.Asn227Ser variant on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.680A>G, p.Asn227Ser variant is classified as Likely Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV001268168 | SCV001446882 | likely pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001265571 | SCV005368396 | likely pathogenic | Intellectual disability, autosomal dominant 45 | 2024-08-23 | criteria provided, single submitter | clinical testing | Criteria applied: PS2,PS4_MOD,PM2,PP3 |
Juno Genomics, |
RCV001265571 | SCV005418060 | likely pathogenic | Intellectual disability, autosomal dominant 45 | criteria provided, single submitter | clinical testing | PM2_Supporting+PP3+PS2+PS4_Supporting |